CGC Financial Services »

Abcellera Biologics shares owned by CGC Financial Services

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by CGC Financial Services from 13F filings

Historical chart of CGC Financial Services investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by CGC Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by CGC Financial Services

Quarter filed Position value Share count Share price at filing
2023-09-30 $184 40 4.60
2023-06-30 $258 40 6.45

More positions owned by CGC Financial Services

Jpmorgan Hedged Equity Laddered Overlay Etf Etf (HELO)
Schwab Us Dividend Equity Etf Etf (SCHD)
Fidelity Enhanced International Etf Etf (FENI)
Ishares S&p 500 Growth Etf Etf (IVW)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Jpmorgan Active Bond Etf Etf (JBND)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Jpmorgan Small & Mid Cap Enhanced Equity Etf Etf (JMEE)
Ishares Msci Intl Momentum Factor Etf Etf (IMTM)
Ishares Russell Top 200 Growth Etf Etf (IWY)
Nuveen Esg Dividend Etf Etf (NUDV)
Apple Stock (AAPL)
Ishares Esg Advanced Msci Usa Etf Etf (USXF)
Nuveen Esg Emerging Markets Equity Etf Etf (NUEM)
Vanguard Growth Etf Etf (VUG)

View all positions for CGC Financial Services

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Two Sigma Investments
Two Sigma Advisers
Arrowpoint Asset Management
BlackRock
Renaissance Technologies
Tang Capital Management
Millennium Management
Susquehanna International
UBS Group
Guardian Partners
Driehaus Capital Management
Citadel Advisors
Arrowstreet Capital, Limited Partnership

View all funds holding Abcellera Biologics